UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials

Addiction (Abingdon, England), 2012-04, Vol.107 (4), p.694-708

2012

Volltextzugriff (PDF)

Buprenorphine Maintenance Therapy in Opioid-Addicted Health Care Professionals Returning to Clinical Practice: A Hidden Controversy

Mayo Clinic proceedings, 2012-08, Vol.87 (8), p.805-806

2012

Volltextzugriff (PDF)

A Qualitative Examination of the Positive and Negative Consequences Associated With Going Tobacco-Free in Substance Abuse Treatment: The NY State Experience

Nicotine & tobacco research, 2012-12, Vol.14 (12), p.1407-1417

2012

Volltextzugriff (PDF)

Protection of patients from physician substance misuse

JAMA : the journal of the American Medical Association, 2013-10, Vol.310 (13), p.1403

Selzer, Jeffrey

2013

Volltextzugriff (PDF)

Comparison of Bifrontal and Bitemporal ECT for Major Depression

The American journal of psychiatry, 2000-01, Vol.157 (1), p.121-123

2000

Volltextzugriff (PDF)

Disseminating evidence-based practices in substance abuse treatment: A review with suggestions

Journal of substance abuse treatment, 2006-07, Vol.31 (1), p.25-39

2006

Volltextzugriff (PDF)

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?

Journal of substance abuse treatment, 2010-06, Vol.38, p.S97-S112

2010

Volltextzugriff (PDF)

Student Substance Use Policies in US Allopathic Medical Schools: A National Study

JAMA psychiatry (Chicago, Ill.), 2021-12, Vol.78 (12), p.1393

2021

Volltextzugriff (PDF)

Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study

Drug and alcohol dependence, 2013-07, Vol.131 (1), p.112-118

2013

Volltextzugriff (PDF)

Buprenorphine tapering schedule and illicit opioid use

Addiction (Abingdon, England), 2009-02, Vol.104 (2), p.256-265

2009

Volltextzugriff (PDF)

Buprenorphine: reflections of an addictions psychiatrist

The journal of clinical psychiatry, 2006-09, Vol.67 (9), p.1466

Selzer, Jeffrey

2006

Volltextzugriff (PDF)

ECT Sessions: How Many a Week?

The American journal of psychiatry, 1996-04, Vol.153 (4), p.585-b-586

1996

Volltextzugriff (PDF)

LONG-SUFFERING OR PROLONGED SUFFERING? TIME MATTERS

Addiction (Abingdon, England), 2009-08, Vol.104 (8), p.1429-1430

2009

Volltextzugriff (PDF)

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial

Archives of general psychiatry, 2011-12, Vol.68 (12), p.1238

2011

Volltextzugriff (PDF)

Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population

The American journal on addictions, 2010-03, Vol.19 (2), p.141-146

2010

Volltextzugriff (PDF)

Milieu complications of the psychiatric inpatient treatment of the AIDS patient

Psychiatric quarterly, 1985, Vol.57 (1), p.77-80

1985

Volltextzugriff (PDF)

Schizophrenia and Substance Abuse

The Psychiatric clinics of North America, 1993-06, Vol.16 (2), p.401-412

1993

Volltextzugriff (PDF)

Multi-site effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?

Journal of substance abuse treatment, 2010-06, Vol.38 (Suppl 1), p.S97-112

2010

Volltextzugriff (PDF)

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?: A Decade of Research by the National Drug Abuse Treatment Clinical Trials Network

Journal of substance abuse treatment, 2010, Vol.38 (4)

2010

Volltextzugriff (PDF)

Considerations on "Organic" Exclusion Criteria for Schizophrenia

Schizophrenia bulletin, 1991, Vol.17 (1), p.69-73

1991

Volltextzugriff (PDF)

Analysing antibody response based on data obtained from serial dilution methods

Statistics in medicine, 1983-10, Vol.2 (4), p.447-454

1983

Volltextzugriff (PDF)

Safety Strategies to Prevent Suicide in Multiple Health Care Environments

Joint Commission journal on quality and safety, 2003-06, Vol.29 (6), p.267-278

2003

Volltextzugriff (PDF)

Smoking

The New England journal of medicine, 1986-01, Vol.314 (3), p.180

1986

Volltextzugriff (PDF)

Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization

The American journal of pediatric hematology/oncology, 1982, Vol.4 (1), p.25

1982

Volltextzugriff (PDF)

Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody

The American journal of pediatric hematology/oncology, 1982, Vol.4 (1), p.19

1982

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials

Buprenorphine Maintenance Therapy in Opioid-Addicted Health Care Professionals Returning to Clinical Practice: A Hidden Controversy

A Qualitative Examination of the Positive and Negative Consequences Associated With Going Tobacco-Free in Substance Abuse Treatment: The NY State Experience

Protection of patients from physician substance misuse

Comparison of Bifrontal and Bitemporal ECT for Major Depression

Disseminating evidence-based practices in substance abuse treatment: A review with suggestions

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?

Student Substance Use Policies in US Allopathic Medical Schools: A National Study

Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study

Buprenorphine tapering schedule and illicit opioid use

Buprenorphine: reflections of an addictions psychiatrist

ECT Sessions: How Many a Week?

LONG-SUFFERING OR PROLONGED SUFFERING? TIME MATTERS

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial

Conducting Clinical Research with Prescription Opioid Dependence: Defining the Population

Milieu complications of the psychiatric inpatient treatment of the AIDS patient

Schizophrenia and Substance Abuse

Multi-site effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?

Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?: A Decade of Research by the National Drug Abuse Treatment Clinical Trials Network

Considerations on "Organic" Exclusion Criteria for Schizophrenia

Analysing antibody response based on data obtained from serial dilution methods

Safety Strategies to Prevent Suicide in Multiple Health Care Environments

Smoking

Pneumococcal polysaccharide immunization of children with sickle cell disease. II. Serologic response and pneumococcal disease following immunization

Pneumococcal polysaccharide immunization of children with sickle cell disease. I. Clinical reactions to immunization and relationship to preimmunization antibody

Suchergebnisse filtern